| Pharmaceutical active ingredients: |
| Budesonide MicronizedFormoterol Fumarate Dihydrate |
| Available forms, composition and doses of Symbicort Turbuhaler Pulverinhalator: |
| Powder; Inhalation; Budesonide Micronized 160 mcg; Formoterol Fumarate Dihydrate 4.5 mcg / dosePowder; Inhalation; Budesonide Micronized 320 mcg; Formoterol Fumarate Dihydrate 9 mcg / dosePowder; Inhalation; Budesonide Micronized 80 mcg; Formoterol Fumarate Dihydrate 4.5 mcg / dose |
| Symbicort Turbuhaler Pulverinhalator medical category: |
| Human:AdrenalsAntiasthmatic and COPD preparationsNasal decongestants and other nasal preparationsSelective beta-2-adrenergic agonistsTopical corticosteroids used as nasal decongestants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R03AK07 - Formoterol and other drugs for obstructive airway diseases |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AstraZeneca |
| Related documents and information about Symbicort Turbuhaler Pulverinhalator: |
| Symbicort prescribing information (PDF)Symbicort medication guide (PDF) |